Back

Astrocytic FABP5 drives non-cell-autonomous oligodendrocyte injury in multiple system atrophy by promoting TNF signaling and ferroptotic stress

Wu, C.; Lin, J.; Chen, Y.; Takahashi, N.; Chen, Q.; Liu, B.; Dai, F.; Zhao, W.; Finkelstein, D. I.; Kawahata, I.; Fukunaga, K.; Cheng, A.

2025-11-10 neuroscience
10.1101/2025.11.08.687320 bioRxiv
Show abstract

Multiple system atrophy (MSA) is a fatal -synucleinopathy characterized by progressive parkinsonism, cerebellar and autonomic dysfunction. Currently, the mechanisms driving cerebellar white matter neuroinflammation and degeneration in MSA are poorly understood. Here, we identified fatty acid-binding protein 5 (FABP5) as a key factor regulating cerebellar inflammation in MSA pathogenesis in a detailed study of human, mouse and cultured astrocytes. Firstly, transcriptomic profiling of human MSA cerebellar white matter revealed activation of pro-inflammatory and ferroptotic pathways, with FABP5 identified as a key pathway component that is upregulated. We confirmed that FABP5 is upregulated in reactive astrocytes in the PLP--syn transgenic mouse model, also in LPS-treated primary astrocytes. Fabp5 silencing suppressed TNF signaling, mitigated ferroptosis, and restored mitochondrial function. These findings suggest astrocytic FABP5 as a central intracellular regulator linking glial inflammation, ferroptosis, and mitochondrial injury. Overall, this mechanism suggests that FABP5 drives pathology mediated by astrocytes oligodendroglia in MSA, therefore representing a novel and promising therapeutic target.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Acta Neuropathologica
51 papers in training set
Top 0.1%
23.7%
2
Brain
154 papers in training set
Top 0.4%
13.2%
3
Nature Communications
4913 papers in training set
Top 31%
5.1%
4
Molecular Neurodegeneration
49 papers in training set
Top 0.2%
3.8%
5
Cell Death & Disease
126 papers in training set
Top 0.4%
3.2%
6
Neurobiology of Disease
134 papers in training set
Top 2%
2.7%
50% of probability mass above
7
Movement Disorders
62 papers in training set
Top 0.6%
2.5%
8
Acta Neuropathologica Communications
81 papers in training set
Top 0.4%
2.2%
9
Molecular Therapy
71 papers in training set
Top 1%
2.2%
10
Advanced Science
249 papers in training set
Top 9%
2.0%
11
Journal of Neuroinflammation
50 papers in training set
Top 0.4%
1.8%
12
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.4%
13
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.3%
1.3%
14
Cell Reports
1338 papers in training set
Top 27%
1.3%
15
eLife
5422 papers in training set
Top 50%
1.2%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 39%
1.0%
17
Annals of Neurology
57 papers in training set
Top 2%
1.0%
18
Communications Biology
886 papers in training set
Top 20%
0.8%
19
Progress in Neurobiology
41 papers in training set
Top 2%
0.8%
20
The Journal of Neuroscience
928 papers in training set
Top 8%
0.8%
21
Gastroenterology
40 papers in training set
Top 2%
0.8%
22
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
23
Science Advances
1098 papers in training set
Top 28%
0.8%
24
PLOS Biology
408 papers in training set
Top 18%
0.8%
25
JCI Insight
241 papers in training set
Top 7%
0.8%
26
Experimental Neurology
57 papers in training set
Top 1%
0.8%
27
npj Parkinson's Disease
89 papers in training set
Top 1.0%
0.8%
28
Glia
74 papers in training set
Top 0.5%
0.8%
29
Clinical and Translational Medicine
30 papers in training set
Top 1%
0.8%
30
Nature Neuroscience
216 papers in training set
Top 7%
0.7%